SCHEMBL31040359

SCHEMBL31040359

CCOC(=O)N1CCC2(CC(N3CCC([C@@H]4CCCN4C(=O)N(N)C(C)(C)C)CC3)C2)C1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 7/20 0.47
▸ CHRM2 P08172 4/20 0.40
▸ CHRM1 P11229 6/20 0.35
▸ TP53 P04637 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ACACB O00763 2/20 0.33
▸ MAPK1 P28482 1/20 0.32
▸ ALDH1A1 P00352 4/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ CHRM5 P08912 1/20 0.31
▸ CHRM3 P20309 1/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16992360 0.89 CHRM4 (0.51) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL16992430 0.89 CHRM4 (0.51) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL20909164 0.88 CHRM4 (0.53) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL16992560 0.88 CHRM4 (0.53) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL18923702 0.86 CHRM4 (0.49) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL16992436 0.86 CHRM4 (0.49) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL16992448 0.86 CHRM4 (0.49) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL16992449 0.86 CHRM4 (0.49) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL16992364 0.86 CHRM4 (0.52) CHRM4CHRM2CHRM1TP53TDP1
SCHEMBL16992049 0.85 CHRM4 (0.47) CHRM4CHRM2CHRM1TP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4714446-A2 PHARMACEUTICAL COMPOUNDS Nxera Pharma UK Limited (GB) 2026-03-25 — — EP disclosed
EP-4413985-A2 PHARMACEUTICAL COMPOUNDS Nxera Pharma UK Limited (GB) 2024-08-14 — — EP disclosed
Send feedback